Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

857 ARTÍCULOS , VIENDO DEL 811 AL 825

Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s disease

Montoliu-Gaya L, Bian S, Dammer EB, Alcolea D, Sauer M, Martá-Ariza M, Ashton NJ, Belbin O, Fuchs J, Watson CM, Ping L, Duong DM, Nilsson J, Barroeta I, Lantero-Rodriguez J, Videla L, Benejam B, Roberts BR, Blennow K, Seyfried NT, Levey AI, Carmona-Iragui M, Gobom J, Lleó A, Wisniewski T, Zetterberg H, Fortea J, Johnson ECB.

Nat Commun. 2025 Jul 1;16(1):6003. doi: 10.1038/s41467-025-61054-z.

Comprehensive evaluation of plasma tau biomarkers for detecting and monitoring Alzheimer's disease in a multicenter and multiethnic aging population

Lan G, Wang M, Gonzalez-Ortiz F, Zhang L, Li A, Li B, Jiang M, Yang J, Chen X, Shi D, Fan X, Cai Y, Sun P, Liu L, Li J, He Z, Fang L, Zhou X, Chen L, Wang Y, Li M, Liu Z, Wang Q, Xu L, Zhou L, Cheng G, Wang X, Ran P, Wang L, Sun K, Han Y, Guan Y, Blennow K, Xie F, Guo T.

Nat Aging. 2025 Aug;5(8):1601-1618. doi: 10.1038/s43587-025-00904-3. Epub 2025 Jun 23.

C-reactive protein-mediated dementia

Tang JM, Lu Q, Lin HX, Li JQ, Zhu XC, Ma T.

Psychogeriatrics. 2025 May;25(3):e70032. doi: 10.1111/psyg.70032.

Blood-based biomarkers for detecting Alzheimer's disease pathology in cognitively impaired individuals within specialized care settings: A systematic review and meta-analysis

Pahlke S, Kahale LA, Mahinrad S, Sousa-Pinto B, Vieira RJ, McAteer MB, Claessen T, Contador J, Hofmann A, Kuchenbecker LA, Machado LS, Warmenhoven N, Yakoub Y, Palmqvist S, Schindler SE, Teunissen C, Whitson HE, Zetterberg H, Edelmayer R, Tampi MP.

Alzheimers Dement. 2025 Nov;21(11):e70828. doi: 10.1002/alz.70828.

Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers

Bouteloup V, Villain N, Vidal JS, Gonzalez-Ortiz F, Yuksekel I, Santos C, Schraen-Maschken S, Pellegrin I, Lehmann S, Blennow K, Chêne G, Hanon O, Dufouil C, Planche V; MEMENTO and the BALTAZAR Study Groups.

JAMA Neurol. 2025 May 1;82(5):506-515. doi: 10.1001/jamaneurol.2025.0142.

Neuroinflammatory fluid biomarkers in patients with Alzheimer's disease: a systematic literature review

Heneka MT, Gauthier S, Chandekar SA, Hviid Hahn-Pedersen J, Bentsen MA, Zetterberg H.

Mol Psychiatry. 2025 Jun;30(6):2783-2798. doi: 10.1038/s41380-025-02939-9. Epub 2025 Mar 6.

Down syndrome and Alzheimer's disease: insights into biomarkers, clinical symptoms, and pathology

Rafii MS, Schlachetzki Z, Barroeta I, Head E, Fortea J, Ances BM.

Lancet Neurol. 2025 Sep;24(9):753-762. doi: 10.1016/S1474-4422(25)00237-6.

Effects of exercise on cognition and Alzheimer's biomarkers in a randomized controlled trial of adults with mild cognitive impairment: The EXERT study

Baker LD, Pa JA, Katula JA, Aslanyan V, Salmon DP, Jacobs DM, Chmelo EA, Hodge H, Morrison R, Matthews G, Brewer J, Jung Y, Rissman RA, Taylor C, Léger GC, Messer K, Evans AC, Okonkwo OC, Shadyab AH, Zou J, Jin S, Thomas RG, Zhang J, La Croix AZ, Cotman CW, Feldman HH; EXERT Study Group.

Alzheimers Dement. 2025 Apr;21(4):e14586. doi: 10.1002/alz.14586.

Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer's disease pathology among cognitively impaired and unimpaired: A systematic review and meta-analysis

Khalafi M, Dartora WJ, McIntire LBJ, Butler TA, Wartchow KM, Hojjati SH, Razlighi QR, Shirbandi K, Zhou L, Chen K, Xi K, Banerjee S, Foldi N, Pahlajani S, Glodzik L, Li Y, de Leon MJ, Chiang GC.

Alzheimers Dement. 2025 Feb;21(2):e14458. doi: 10.1002/alz.14458. Epub 2024 Dec 23.

Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings

Palmqvist S, Whitson HE, Allen LA, Suarez-Calvet M, Galasko D, Karikari TK, Okrahvi HR, Paczynski M, Schindler SE, Teunissen CE, Zetterberg H, Carrillo MC, Edelmayer RM, Mahinrad S, McAteer MB, Kahale LA, Pahlke S, Tampi MP.

Alzheimers Dement. 2025 Jul;21(7):e70535. doi: 10.1002/alz.70535.

Treatment of Restless Legs Syndrome Improves Agitation and Sleep in Persons with Dementia: A Randomized Trial

Richards KC, Fry LM, Lozano AJ, Ji W, Morrison JD, Britt KC, Bliwise DL, Gooneratne NS, Hanlon AL.

J Am Med Dir Assoc. 2025 May;26(5):105485. doi: 10.1016/j.jamda.2025.105485. Epub 2025 Mar 31.

Sleep disorders increase the risk of dementia, Alzheimer's disease, and cognitive decline: a meta-analysis

Ungvari Z, Fekete M, Lehoczki A, Munkácsy G, Fekete JT, Zábó V, Purebl G, Varga P, Ungvari A, Győrffy B.

Geroscience. 2025 Jun;47(3):4899-4920. doi: 10.1007/s11357-025-01637-2. Epub 2025 Apr 11.

Sleep disorders and the risk of cognitive decline or dementia: an updated systematic review and meta-analysis of longitudinal studies

Zhang J, Ou J, Lu X, Wang T, Dang W, Ding L, Liu Y, Xu J, Yan B, Yu H.

J Neurol. 2025 Oct 13;272(10):689. doi: 10.1007/s00415-025-13372-x.

The three clap test: a window into cognitive and frontal lobe dysfunction

Brežná Z, Typčuková KĎ, Necpál J.

Neurol Sci. 2025 Mar;46(3):1103-1110. doi: 10.1007/s10072-024-07902-0. Epub 2024 Nov 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias